Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
13.00
+0.08 (0.62%)
Aug 15, 2025, 10:41 AM - Market open

Adaptive Biotechnologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-121.23-159.49-225.25-200.19-207.28-146.23
Upgrade
Depreciation & Amortization
18.2719.2622.2320.9213.958.47
Upgrade
Asset Writedown & Restructuring Costs
0.017.2125.43---
Upgrade
Loss (Gain) From Sale of Investments
-5.17-8.21-9.180.747.230.77
Upgrade
Stock-Based Compensation
51.8653.6162.9155.4843.2524.76
Upgrade
Other Operating Activities
7.219.8713.7310.656.933.34
Upgrade
Change in Accounts Receivable
-8.67-3.742.03-22.65-7.362.61
Upgrade
Change in Inventory
5.445.37-2.840.82-5.2-4.99
Upgrade
Change in Accounts Payable
-2.190.67-5.417.113.947.5
Upgrade
Change in Unearned Revenue
-15.74-10.48-29.29-56.5-57.73-43.39
Upgrade
Change in Other Net Operating Assets
-10.26-9.28-10.68-0.339.53-2.52
Upgrade
Operating Cash Flow
-80.47-95.21-156.32-183.95-192.73-149.68
Upgrade
Capital Expenditures
-2.34-3.66-10.7-16.35-61.75-18.8
Upgrade
Investment in Securities
58.6681.46140.3419.25242.96-98.24
Upgrade
Investing Cash Flow
56.3377.79129.652.91181.21-117.04
Upgrade
Issuance of Common Stock
7.230.242.257.8926.72293.91
Upgrade
Other Financing Activities
---124.380.43-0.32
Upgrade
Financing Cash Flow
7.230.242.25132.2727.15293.59
Upgrade
Net Cash Flow
-16.92-17.18-24.43-48.7815.6326.86
Upgrade
Free Cash Flow
-82.81-98.88-167.02-200.29-254.47-168.49
Upgrade
Free Cash Flow Margin
-40.35%-55.25%-98.09%-108.09%-164.87%-171.26%
Upgrade
Free Cash Flow Per Share
-0.56-0.67-1.16-1.41-1.81-1.28
Upgrade
Cash Interest Paid
9.488.868.990.49--
Upgrade
Levered Free Cash Flow
-18.76-24.48-81.95-90.17-139.1-60.55
Upgrade
Unlevered Free Cash Flow
-11.42-17.24-73.33-87.53-139.1-60.55
Upgrade
Change in Working Capital
-31.42-17.45-46.18-71.55-56.82-40.8
Upgrade
Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q